Burning Rock Biotech Limited: cashflow_investing
| Value | {"amount": -1309000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | Burning Rock Biotech Limited |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:06:29.629507+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/01c91598-a4ad-4241-904c-0620310f38a9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-24-119655Retrieved: 2026-08-19T18:06:29.629507+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001792267/cashflow-investing/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/01c91598-a4ad-4241-904c-0620310f38a9
History
- supersedes {"unit": "CNY", "value": -9300000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities"} (evidence 0001193125-24-119655)